Comorbid ADHD and Schizophrenia and the Use of Psychostimulants: A Scoping Review Protocol

This scoping review protocol systematically examines evidence for the potential harms and benefits of psychostimulant medications in patients with both ADHD and schizophrenia, where clinical guidance is currently limited and concerns exist about safety. The review will synthesize literature from major medical databases using established methodology to identify the current evidence base and research gaps in this understudied population.